Polho, G. B., Soares, G., Muniz, D. Q. B., Coelho, R. F., Cardili, L., Barbosa, F. G., Ilario, E. N., Viana, P., Murta, C. B., Guglielmetti, G., Cordeiro, M., Jr, J. P., Silva, J. A., Mota, J. M., Freitas, G. F. D., Leite, K. R. M., Buchpiguel, C. A., Nahas, W. C., Bastos, D. A. (2026). Neoadjuvant androgen receptor pathway inhibition for patients with high-risk localized prostate cancer: 5-year survival update and PSMA PET correlatives of the randomized NeoPRO trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5119